Drawing for DIGITALBRIDGE

USPTO serial 98849225

DIGITALBRIDGE

Reviewed by CopyMark Law Group

Status 688Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
ROSEN, BENJAMIN H
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 688: Status 688 means a Notice of Allowance was issued. For intent-to-use applications, you must file a Statement of Use with specimens or request an extension before the deadline — usually six months from the notice date.

Need help with DIGITALBRIDGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $996*

Plus Government fees of $500

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. David Galin

M. David Galin Tucker Ellis LLP950 Main Avenue, Suite 1100Cleveland, OH 44113United States

Goods and services

ClassDescriptionStatusFirst use
010Medical and veterinary apparatus and instruments for neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; medical and veterinary apparatus and instruments for the restoration, support, control and regulation of autonomic and sacral functions; Medical diagnostic examination and monitoring apparatus for use in treatment of patients in the neurostimulation, neuromodulation, neurorehabilitation, neurosensing, nerual coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation fields for testing neural-muscular function, neural function, and neurostimulation response; spinal implants composed of artificial material and prosthetic neural implants; Electromedical rehabilitative and pain management products for clinical and home use, namely, electric nerve stimulators; Electromedical rehabilitative and pain management products for clinical and home use, namely, electronic nerve stimulators; Electronic nerve and muscle stimulators for medical purposes; transcutaneous electrical muscle stimulators for medical purposes; electronic nerve and muscle stimulators for neurostimulation, neuromodulation, neurorehabilitation, neurorecovery, neuroregeneration and physical rehabilitation for medical purposes; electrical leads for use with implantable nerve stimulators for medical use; medical apparatus and instruments for the treatments of patients with neuromotor impairment and/or neuropathies and/or paraplegia and/or locomotion disabilities or handicaps; orthopedic and mobility aids, namely, orthopedic walkers and canes for medical purposes; medical supports for legs and arms; compression garments; chemically activated hot and/or cold body support compression garments; compression socks; bandages for supporting the human body in the nature of support bandagesACTIVE—
028Exercise treadmills for medical useACTIVE—
042Computer technical services for support in the use of medical apparatus and instruments in the fields of neurostimulation, neuromodulation, neuro-rehabilitation, neursensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation, namely, 24/7 support desk services for IT infrastructure, operating systems, database systems, and web applications; science and technology services in the nature of medical research and development of device-based treatments for the treatment of diseases in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neuroregeneration, neurorecovery, and physical rehabilitation; testing, authentication and quality control for others of medical apparatus and instruments in the fields of neurostimulation, neuromodulation, neuro-rehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; design services for medical apparatus and instruments relating to neurostimulators, neuromodulators, neuro-rehabilitators, neurosensors, neural coders, neural decoders, neuroregenerators and physical rehabilitation devices, all for medical, scientific, and technological applications; medical research services in the fields of neurostimulation, neuromodulation, neuro-rehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; medical research in the field of natural science; clinical research in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuro-regeneration, and physical rehabilitation; biomedical research services in the fields of neurostimulation, neuromodulation, neuro-rehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; Medical and scientific research, namely, conducting clinical trials for others in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration, and physical rehabilitation for others; Scientific research in the nature of conducting clinical trials for others in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration, and physical rehabilitation; medical research in the fields of neurostimulation, neuromodulation, neuro- rehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; scientific investigations for medical purposes in the fields of neurostimulation, neuromodulation, neuro-rehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; engineering research in the fields of neurostimulation, neuromodulation, neuro-rehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; software engineering services in the fields of neurostimulation, neuromodulation, neuro-rehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation; mechanical engineering, namely, medical engineering in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration, and physical rehabilitationACTIVE—
044Medical rehabilitation patient care services regarding the restoration, support, control and regulation of autonomic and sacral functions; providing physical rehabilitation facilities providing neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration in the nature of physical rehabilitation services; development of individual physical rehabilitation programs in the nature of physical rehabilitation; provision of exercise facilities specifically for health rehabilitation services in the nature of providing physical rehabilitation facilities; consulting services in the fields of neurostimulation, neuromodulation, neurorehabilitation, neurosensing, neural coding, neural decoding, neurorecovery, neuroregeneration and physical rehabilitation servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 13, 2026D1BRTEAS DELETE 1(B) BASIS RECEIVED—
May 12, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 9, 2026DOCKASSIGNED TO EXAMINER—
Nov 6, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 6, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 6, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 5, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 5, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 8, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 8, 2025DOCKASSIGNED TO EXAMINER—
Apr 26, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 12, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance